Blog Confidentiality Public Domain 
Kashishipr
APRIL 20, 2022
A still-new form of IP that has gained recognition in the past two decades is trade secrets, which we shall be discussing here in this blog. In simple terms, trade secrets are Intellectual Property Rights (IPRs) granted on confidential or sensitive info, which may be licensed or sold. Information Protected by a Trade Secret .
JIPL Online
MARCH 15, 2021
1] This blog will briefly summarize a few of the notable copyright infringement cases Netflix has defended against in the United States. 2] While most Sherlock Holmes stories are now in the public domain, the estate alleged that some works and character elements regarding Sherlock Holmes are still protected by copyright. [3]
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SpicyIP
JULY 9, 2021
Trade secrets are not limited by the number of years unlike patent protection which lasts for 20 years and upon expiration thrusts the invention into public domain. Managing confidentiality and employee relationships can be unthrifty. However, Delhi High Court in the case of Prof. Dr. Claudio de Simone v.
Kashishipr
FEBRUARY 16, 2022
Therefore, a business company or organization should consider whether it is suitable to sign a non-disclosure agreement to safeguard and not misuse any piece of info it considers confidential, valuable, and not belonging to the public domain. appeared first on Blog | Kashish IPR | Intellectual Property Rights Law Firm.
Velocity of Content
JANUARY 22, 2025
They might share confidential work information too freely or hesitate to report errors out of a misplaced sense of loyalty. As we have seen in this blog, it extends into significant practical challenges around copyright law and business compliance.
Technology & Marketing Law Blog
DECEMBER 15, 2021
As I’ve blogged many, many times on this blog (see list below), 512(f) has been a complete failure. The Lenz case got a lot of press, but it ended with a confidential settlement. A few plaintiffs have won default judgments (including one I blog below). 512(f) is a cause of action for abusive takedown notices.
The IPKat
NOVEMBER 14, 2022
However the two recent posts of this very same blog, one on the preliminary opinion of EBA on plausibility (G2/21, here ), the other on the requisite of sufficiency of disclosure for a first medical use patent (T0424/21, here ) have removed any doubt on whether or not to try and cover it.
Expert insights. Personalized for you.
119 
Let's personalize your content